Copyright
©The Author(s) 2017.
World J Gastroenterol. Aug 7, 2017; 23(29): 5356-5363
Published online Aug 7, 2017. doi: 10.3748/wjg.v23.i29.5356
Published online Aug 7, 2017. doi: 10.3748/wjg.v23.i29.5356
Table 1 Analysis of correlation between isoflavone intakes and number of bowel movements per day declared in group of ulcerative colitis individuals (analysis conducted using Spearman rank correlation coefficient)
P value | R | |
Intake | ||
Daidzein (mg) | 0.0889 | -0.2509 |
Genistein (mg) | 0.2942 | 0.1543 |
Glycitein (mg) | 0.1889 | 0.1946 |
Total isoflavones (mg) | 0.8987 | 0.0191 |
Intake per 1000 kcal | ||
Daidzein (mg/1000 kcal) | 0.0992 | -0.2434 |
Genistein (mg/1000 kcal) | 0.2762 | 0.1621 |
Glycitein (mg/1000 kcal) | 0.1899 | 0.1946 |
Total isoflavones (mg/1000 kcal) | 0.9881 | -0.0022 |
Table 2 Isoflavone intake levels in groups of ulcerative colitis individuals declaring lack of abdominal pain and declaring presence of abdominal pain (comparison conducted using U Mann-Whitney test)
Individuals declaring lack of abdominal pain(n = 29) | Individuals declaring abdominal pain(n = 27) | P value | |||
Mean ± SD | Median (min-max) | Mean ± SD | Median (min-max) | ||
Intake | |||||
Daidzein (μg) | 168.3 ± 112.5 | 176.7 (4.3-476.7) | 119.1 ± 187.2 | 68.01 (3.3-977.7) | 0.0075 |
Genistein (μg) | 177.9 ± 127.6 | 156.7 (5.3-444.0) | 177.1 ± 287.0 | 125.31 (2.3-1428.3) | 0.1356 |
Glycitein (μg) | 0.5 ± 2.6 | 0.01 (0.0-14.0) | 3.4 ± 12.3 | 0.01 (0.0-56.0) | 0.2706 |
Total isoflavones (μg) | 346.6 ± 185.2 | 333.3 (7.7-770.7) | 299.6 ± 362.2 | 177.31 (18.0-1574.0) | 0.0358 |
Intake per 1000 kcal | |||||
Daidzein (μg/1000 kcal) | 94.6 ± 86.1 | 69.91 (1.3-347.7) | 60.4 ± 79.1 | 46.21 (2.1-392.7) | 0.0358 |
Genistein (μg/1000 kcal) | 88.3 ± 69.6 | 86.21 (1.6-279.5) | 100.4 ± 161.4 | 57.41 (1.4-759.2) | 0.2378 |
Glycitein (μg/1000 kcal) | 0.3 ± 1.5 | 0.01 (0.0-8.0) | 2.1 ± 7.8 | 0.01 (0.0-37.4) | 0.2706 |
Total isoflavones (μg/1000 kcal) | 183.1 ± 130.9 | 137.2 (8.3-517.2) | 162.9 ± 193.5 | 119.71 (8.6-836.7) | 0.1400 |
Table 3 Isoflavone intake levels in groups of ulcerative colitis individuals declaring lack of flatulence and declaring presence of flatulence (comparison conducted using U Mann-Whitney test)
Individuals declaring lack of flatulence (n = 46) | Individuals declaring flatulence (n = 10) | P value | |||
Mean ± SD | Median (min-max) | Mean ± SD | Median (min-max) | ||
Intake | |||||
Daidzein (μg) | 147.4 ± 165.6 | 115.01 (3.3-977.7) | 131.4 ± 843 | 109.8 (19.0-278.0) | 0.7727 |
Genistein (μg) | 187.6 ± 225.4 | 140.01 (2.3-1428.3) | 131.1 ± 177.6 | 78.31 (7.3-586.7) | 0.2186 |
Glycitein (μg) | 2.2 ± 9.7 | 0.01 (0.0-56.0) | 0.4 ± 1.3 | 0.01 (0.0-4.0) | 0.7738 |
Total isoflavones (μg) | 337.2 ± 293.4 | 302.51 (18.0-1574.0) | 262.9 ± 232.2 | 220.81 (37.3-833.0) | 0.4162 |
Intake per 1000 kcal | |||||
Daidzein (μg/1000 kcal) | 78.9 ± 89.1 | 53.91 (1.3-392.7) | 74.3 ± 56.6 | 60.8 (12.1-56.6) | 0.6455 |
Genistein (μg/1000 kcal) | 97.3 ± 121.5 | 68.11 (1.4-759.2) | 79.4 ± 128.7 | 32.31 (3.6-426.6) | 0.2268 |
Glycitein (μg/1000 kcal) | 1.4 ± 6.1 | 0.01 (0.0-37.4) | 0.3 ± 0.9 | 0.01 (0.0-2.9) | 0.7738 |
Total isoflavones (μg /1000 kcal) | 177.6 ± 162.9 | 133.51 (8.3-836.7) | 154.0 ± 170.0 | 133.91 (21.7-605.7) | 0.5854 |
Table 4 Isoflavone intake levels in groups of ulcerative colitis individuals declaring lack of constipations and declaring presence of constipations (comparison conducted using U Mann-Whitney test)
Individuals declaring lack of constipations(n = 49) | Individuals declaring constipations(n = 7) | P value | |||
Mean ± SD | Median (min-max) | Mean ± SD | Median (min-max) | ||
Intake | |||||
Daidzein (μg) | 147.0 ± 158.0 | 117.71 (3.3-977.7) | 127.0 ± 128.6 | 73.0 (11.3-353.0) | 0.6827 |
Genistein (μg) | 183.6 ± 219.9 | 137.01 (2.3-1428.3) | 134.9 ± 208.8 | 67.01 (6.7-586.7) | 0.1891 |
Glycitein (μg) | 1.0 ± 5.1 | 0.01 (0.0-33.3) | 8.6 ± 21.0 | 0.01 (0.0-56.0) | 0.0213 |
Total isoflavones (μg) | 331.6 ± 282.8 | 262.71 (27.7-1574.0) | 270.5 ± 300.4 | 123.7 (18.0-833.0) | 0.3339 |
Intake per 1000 kcal | |||||
Daidzein (μg/1000 kcal) | 146.8 ± 161.0 | 117.71 (3.3-977.7) | 101.1 ± 124.2 | 46.2 (5.4-347.7) | 0.9802 |
Genistein (μg/1000 kcal) | 183.3 ± 224.2 | 137.01 (2.3-1428.3) | 97.6 ± 152.0 | 37.11 (3.2-426.6) | 0.4279 |
Glycitein (μg/1000 kcal) | 1.0 ± 5.2 | 0.01 (0.0-33.3) | 5.7 ± 6.7 | 0.01 (0.0-37.4) | 0.0213 |
Total isoflavones (μg/1000 kcal) | 331.1 ± 287.9 | 262.71 (27.7-1574.0) | 204.5 ± 236.1 | 68.4 (8.6-605.7) | 0.7102 |
Table 5 Isoflavone intake levels in groups of ulcerative colitis individuals declaring lack of tenesmus and declaring presence of tenesmus (comparison conducted using U Mann-Whitney test)
Individuals declaring lack of constipations(n = 47) | Individuals declaring constipations(n = 9) | P value | |||
Mean ± SD | Median (min-max) | Mean ± SD | Median (min-max) | ||
Intake | |||||
Daidzein (μg) | 124.5 ± 107.8 | 101.01 (3.3-476.7) | 249.4 ± 284.4 | 205.71 (5.3-977.7) | 0.0818 |
Genistein (μg) | 190.4 ± 233.0 | 138.01 (2.3-1428.3) | 110.0 ± 79.7 | 126.0 (7.3-253.7) | 0.3662 |
Glycitein (μg) | 2.3 ± 9.6 | 0.01 (0.0-56.0) | 0.0 ± 0.0 | 0.01 (0.0-0.0) | 0.3819 |
Total isoflavones (μg) | 317.2 ± 280.2 | 302.31 (18.0-1574.0) | 359.4 ± 311.7 | 242.31 (139.3-1137.7) | 0.7379 |
Intake per 1000 kcal | |||||
Daidzein (μg/1000 kcal) | 70.6 ± 76.7 | 48.11 (1.3-347.7) | 117.2 ± 111.6 | 95.11 (4.5-392.7) | 0.0943 |
Genistein (μg/1000 kcal) | 101.4 ± 130.7 | 69.11 (1.4-759.2) | 55.7 ± 42.5 | 46.5 (3.6-117.4) | 0.3722 |
Glycitein (μg/1000 kcal) | 1.4 ± 6.1 | 0.01 (0.0-37.4) | 0.0 ± 0.0 | 0.01 (0.0-0.0) | 0.3819 |
Total isoflavones (μg/1000 kcal) | 173.4 ± 171.7 | 131.21 (8.3-836.7) | 173.0 ± 113.5 | 140.91 (73.4-456.9) | 0.5770 |
- Citation: Głąbska D, Guzek D, Grudzińska D, Lech G. Influence of dietary isoflavone intake on gastrointestinal symptoms in ulcerative colitis individuals in remission. World J Gastroenterol 2017; 23(29): 5356-5363
- URL: https://www.wjgnet.com/1007-9327/full/v23/i29/5356.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i29.5356